White House Pulls FDA Nominee as Senate Support Slips

The administration withdrew its FDA pick after signs of resistance in the Senate. The move leaves the agency under an acting leader at a time when drug, vaccine and advisory-panel work continues.
GLP-1 Weight-Loss Drugs: Rare Harms, Real Tradeoffs

New reporting and medical evidence are sharpening the picture of GLP-1 drug safety: serious complications appear uncommon, but some risks are real and worth discussing before and during treatment.
FDA Eases Path for Some Peptide Compounds Amid Safety Debate

The federal government has moved to make some compounded peptide products more available even as FDA staff have warned the evidence for safety and effectiveness is thin.
FDA Moves to Update Infant Formula Nutrition Rules

Federal regulators have proposed changes to long-standing infant formula nutrition standards, including updated targets for several nutrients and a fresh review of how formulas are labeled.
When Cancer Drugs Run Short, Patients Feel the Gap

A Washington Post report describes how some U.S. cancer patients and clinicians are turning to overseas sources when key medicines run short. The broader pattern reflects a stubborn reality: shortages can delay treatment, force substitutions, and create new safety questions.
Updated Menopause Guidance Reassesses Hormone Therapy

New guidance is putting hormone therapy back at the center of menopause care for some people with hot flashes and night sweats, while keeping safety limits and individual risk factors in view.
What consumers should know about unregulated peptide products

A Washington Post report highlights people who say they felt worse after using experimental peptides, while FDA warnings underline that many of these products have not been proven safe or effective.
What to Know Before Choosing a Galleri Cancer Blood Test

A Washington Post health column explores the appeal of Galleri, a multi-cancer blood test. The evidence suggests promise, but major questions remain about benefits, harms, and who should consider it.
A Chat Interface for Medical Devices Raises New Possibilities — and New Safety Questions

Researchers are testing an AI-powered platform that could let people exchange real-time messages with certain medical devices. The promise is faster feedback, but the safety and oversight questions are substantial.
AI Is Reshaping Breast Cancer Screening, but the Evidence Is Still Evolving

New imaging software is helping radiologists spot breast cancer risk and suspicious findings, but researchers say the benefits, limits, and best uses of AI are still being studied.